Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
European Journal of Drug Metabolism and Pharmacokinetics|July 21, 2018
Reduced Clearance of Phenobarbital in Advanced Cancer Patients near the End of LifeHirokazu Nakayama, Hirotoshi Echizen, Ryuichi Ogawa, et al.International Journal of Clinical Pharmacology and Therapeutics|March 6, 2013
Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infectionRyuichi Ogawa, Seiichi Kobayashi, Yuki Sasaki, et al.Journal of Pharmaceutical Health Care and Sciences|January 25, 2017
Impact of Pharmacists' audit on improving the quality of prescription of dabigatran etexilate methanesulfonate: a retrospective studyTeppei Shimizu, Yoshio Momose, Ryuichi Ogawa, et al.Biological & Pharmaceutical Bulletin|May 8, 2020
Clinical Predictors of the Hypoglycemic Effect of Sodium-Glucose Co-transporter-2 Inhibitors in Hyperuricemic Patients: A Retrospective Descriptive Observational StudyToshinori Hirai, Yuya Kawagoe, Motoki Kei, et al.Biological & Pharmaceutical Bulletin|February 3, 2016
Eculizumab Dosing Intervals Longer than 17 Days May Be Associated with Greater Risk of Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal HemoglobinuriaHirokazu Nakayama, Kensuke Usuki, Hirotoshi Echizen, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 2, 2007
[Analysis of clinical factors that influence re-stenosis after percutaneous coronary stenting]Sachiko Asamasu-Sato, Mitsuo Mita, Ryuichi Ogawa, et al.The Journal of Dermatological Treatment|July 28, 2025
Initiation of apremilast treatment decreases prescribed topical therapy amount in patients with psoriasis: a health insurance claims study in JapanSiddharth Chaudhari, Ryuichi Ogawa, Shinichi Imafuku, et al.Biological & Pharmaceutical Bulletin|July 2, 2019
Relationship between Recurrent Falls and Medication Use during Acute-Care Hospitalization: A Retrospective Descriptive StudyToshinori Hirai, Yutori Ishikawa, Yuya Kawagoe, et al.Therapeutic Drug Monitoring|March 23, 2017
Induration at Injection or Infusion Site May Reduce Bioavailability of Parenteral Phenobarbital AdministrationHirokazu Nakayama, Hirotoshi Echizen, Ryuichi Ogawa, et al.The Annals of Pharmacotherapy|January 4, 2007
Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel diseaseYukari Masunaga, Keiko Ohno, Ryuichi Ogawa, et al.Pageof 4